Literature DB >> 26721317

A de novo mutation of the LDL receptor gene as the cause of familial hypercholesterolemia identified using whole exome sequencing.

Hayato Tada1, Kazuyoshi Hosomichi2, Hirofumi Okada3, Masa-Aki Kawashiri3, Atsushi Nohara4, Akihiro Inazu5, Shigeru Tomizawa6, Atsushi Tajima2, Hiroshi Mabuchi4, Kenshi Hayashi3.   

Abstract

We report a rare case of heterozygous familial hypercholesterolemia (FH) caused by a de novo mutation in LDL receptor (LDLR) gene identified using whole exome sequencing. An 11-year-old female without any family histories of hypercholesterolemia was referred to our hospital to make clinical as well as molecular diagnoses. She was first diagnosed as hypercholesterolemia at the age of 3 (initial total cholesterol=381mg/dl) without any secondary causes. Because of her lipid profile, heterozygous FH was initially suspected, however; the lipid levels of her parents were normal. Accordingly, she was suspected as a recessive form of hypercholesterolemia, such as sitosterolemia or autosomal recessive hypercholesterolemia. Whole exome sequencing was performed on 4 individuals, including the proband, her parents, and her unaffected younger sister. The initial analysis assuming a recessive inheritance was unsuccessful, leaving a few candidate genes without any evidence supporting cholesterol metabolism. However, we found only one de novo mutation in LDLR gene across her whole exome region, assuming de novo mutation occurrence (c.1136G>A or p.Cys379Tyr). This mutation has already been reported to cause FH, including Japanese, and finally, she was diagnosed as heterozygous FH caused by a de novo mutation in LDLR gene. Comprehensive genetic analysis is quite useful to make a correct diagnosis in such cases.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Familial hypercholesterolemia; LDL cholesterol; LDLR; Whole exome sequencing; de novo mutation

Mesh:

Substances:

Year:  2015        PMID: 26721317     DOI: 10.1016/j.cca.2015.12.028

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

Review 1.  Clinical Perspectives of Genetic Analyses on Dyslipidemia and Coronary Artery Disease.

Authors:  Hayato Tada; Masa-Aki Kawashiri; Masakazu Yamagishi
Journal:  J Atheroscler Thromb       Date:  2017-02-28       Impact factor: 4.928

2.  Challenges of Precision Medicine for Atherosclerotic Cardiovascular Disease Based on Human Genome Information.

Authors:  Hayato Tada; Soichiro Usui; Kenji Sakata; Masayuki Takamura; Masa-Aki Kawashiri
Journal:  J Atheroscler Thromb       Date:  2020-11-21       Impact factor: 4.928

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.